| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2024 | 14 May 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Financial Results of the company for the quarter and year ended 31st March 2024 Outcome of the Board Meeting and Submission of Audited Financial Results for the Quarter and Financial Year ended 31stMarch, 2024 as required u/r 33 of the SEBI (LODR) Regulations, 2015. Disclosure of change in management (As Per BSE Announcement Dated on 30.05.2024) | ||
| Board Meeting | 26 Mar 2024 | 14 Mar 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 inter alia to consider and approve Dear Sir Pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations 2015 and Schedule IV of the Companies Act 2013 notice is hereby given that a separate meeting of Independent Directors of the company is scheduled to be held on Tuesday 26 th March 2024 at 03:00 P.M. at the corporate office of the company. at 703 Arunachal Building 19 Barakhamba Road Connaught Place New Delhi-110001 to inter-alia transact the following business: I. To review the performance of non-Independent Directors and the Board as a whole; II. To assess the quality quantity and timeliness of flow of information between the company management and the Board that is necessary for the Board to effectively and reasonably perform their duties; Outcome of Independent Directors Meeting (As Per BSE Announcement Dated on 26/03/2024) | ||
| Board Meeting | 13 Feb 2024 | 1 Feb 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter & nine months ended 31st December 2023 This is to inform you that pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Tuesday, 13 th February, 2024 at 04:30 P.M at the corporate office of the company situated at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded just now has, inter-alia, transacted the following business: 1. Considered and approved the Standalone Un-Audited Financial Results of the Companyfor the quarter and nine months ended 31 st December, 2023. 2. Considered and approved the Limited Review Report for the Un-Audited Financial Results of the Company for the quarter and nine months ended 31 st December, 2023. Further pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, a copy of the aforesaid Un-Audited Financial Results for the quarter and nine months ended 31st December, 2023along with Limited Review Report are enclosed herewith pfa (As Per BSE Announcement Dated on 13/02/2024) | ||
| Board Meeting | 9 Nov 2023 | 30 Oct 2023 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations 2015 notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations 2015 a meeting of the Board of Directors of the company is scheduled to be held on Thursday 09th November 2023 at 04:30 P.M. at the corporate office of the company at 703 Arunachal Building 19 Barakhambha Road Connaught Place New Delhi-110001 to inter-alia consider and approve the Unaudited Financial Results of the Company & Limited Review Report thereon for the quarter and half year ended 30th September 2023 and to carry on any other business with the permission of the Board. Submission of unaudited financial results for the quarter and half year ended 30th September, 2023 Outcome and submission of the results for the half year ended 30th September , 2023 (As per BSE Announcement Dated on 09/11/2023) | ||
| Board Meeting | 29 Aug 2023 | 23 Aug 2023 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2023 inter alia to consider and approve the notice calling the Annual General Meeting (AGM) Directors Report Management Discussion and Analysis Report & Corporate Governance Report and Annexures thereto for the Financial Year 2022-23 Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 , we wish to inform you that Board of Directors in its meeting held today i.e. on Tuesday, 29th August, 2023 at 04:00 P.M. at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, and concluded at 04:45 P.M. has inter-alia, transacted the enclosed business . (As per BSE Announcement Dated on 29/08/2023) | ||
| Board Meeting | 12 Aug 2023 | 2 Aug 2023 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations 2015 notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations 2015 a meeting of the Board of Directors of the company is scheduled to be held on Saturday 12th August 2023 at 04:30 P.M at the corporate office of the company at 703 Arunachal Building 19 Barakhambha Road Connaught Place New Delhi- 110001 to inter-alia consider and approve the Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter ended 30th June 2023 and to carry on any other business with the permission of the Board. Please find attached unaudited fincial results for the quarter ended on 30th june, 2023 (As per BSE Announcement Dated on 12/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
